Exogenesis Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Out of Business

Exogenesis General Information

Description

Developer of a surface modification technology designed to improve the safety and efficacy of implantable medical devices. The company's technology helps to modify the physical and chemical properties of the outermost atomic layers of the surface while leaving the underlying bulk of the unaffected material, enabling physicians to avail the anti-adhesive properties of a surface to platelets while promoting endothelial cell attachment and proliferation.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 20 Fortune Drive
  • Billerica, MA 01821
  • United States
+1 (978)
Primary Industry
Other Devices and Supplies
Corporate Office
  • 20 Fortune Drive
  • Billerica, MA 01821
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exogenesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 27-Apr-2026 Completed Out of Business
6. Later Stage VC Completed Generating Revenue
5. Debt - PPP 03-May-2020 Completed Generating Revenue
4. Later Stage VC 03-May-2016 Completed Generating Revenue
3. Later Stage VC Completed Generating Revenue
2. Later Stage VC (Series B) 29-Nov-2010 $3.19M $10.4M Completed Generating Revenue
1. Later Stage VC (Series A) 09-Aug-2010 $7.19M $7.19M Completed Generating Revenue
To view Exogenesis’s complete valuation and funding history, request access »

Exogenesis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Exogenesis’s complete cap table history, request access »

Exogenesis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a surface modification technology designed to improve the safety and efficacy of implantable medical device
Other Devices and Supplies
Billerica, MA
14 As of 2025

Otawara, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Exogenesis Competitors (1)

One of Exogenesis’s competitors is Canon Medical Systems, a Corporate Backed or Acquired company based in Otawara, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Canon Medical Systems Corporate Backed or Acquired Otawara, Japan
You’re viewing 1 of 1 competitors. Get the full list »

Exogenesis Patents

Exogenesis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240018003-A1 Using anab technology to remove production processing residuals from graphene Pending 29-Jun-2022
WO-2023278386-A1 Protection of orthopedic implants from wear Inactive 28-Jun-2021
EP-4320084-A1 Method and apparatus for forming substrate surfaces with exposed crystal lattice using accelerated neutral atom beam Inactive 08-Apr-2021
WO-2022217102-A1 Method and apparatus for forming substrate surfaces with exposed crystal lattice using accelerated neutral atom beam Inactive 08-Apr-2021
WO-2022217102-A9 Method and apparatus for forming substrate surfaces with exposed crystal lattice using accelerated neutral atom beam Inactive 08-Apr-2021 H10P14/6309
To view Exogenesis’s complete patent history, request access »

Exogenesis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exogenesis Investments (1)

Exogenesis’s most recent deal was a Joint Venture with ANAB technology (Exogenesis/SEMATECH). The deal was made on 04-May-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ANAB technology (Exogenesis/SEMATECH) 04-May-2015 Joint Venture Production (Semiconductors)
To view Exogenesis’s complete investments history, request access »

Exogenesis FAQs

  • When was Exogenesis founded?

    Exogenesis was founded in 2005.

  • Where is Exogenesis headquartered?

    Exogenesis is headquartered in Billerica, MA.

  • What is the size of Exogenesis?

    Exogenesis has 14 total employees.

  • What industry is Exogenesis in?

    Exogenesis’s primary industry is Other Devices and Supplies.

  • Is Exogenesis a private or public company?

    Exogenesis is a Private company.

  • What is Exogenesis’s current revenue?

    The current revenue for Exogenesis is .

  • How much funding has Exogenesis raised over time?

    Exogenesis has raised $22.7M.

  • Who are Exogenesis’s competitors?

    Canon Medical Systems is a competitor of Exogenesis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process